Global Particle Therapy Market Size By Type (Proton, Heavy Ion), By Product (Cyclotrons, Synchrotrons, Synchrocyclotrons), By Cancer Type (Pediatric, Prostate, Lung, Breast), By Geographic Scope And Forecast
Report ID: 40167|No. of Pages: 202
Global Particle Therapy Market Size By Type (Proton, Heavy Ion), By Product (Cyclotrons, Synchrotrons, Synchrocyclotrons), By Cancer Type (Pediatric, Prostate, Lung, Breast), By Geographic Scope And Forecast
Particle Therapy Market Size And Forecast
Particle Therapy Market size was valued at USD 1236.94 Million in 2023 and is projected to reach USD 2573.45 Million by 2031, growing at a CAGR of 9.59% from 2024 to 2031.
- Particle therapy is a type of external beam radiotherapy that uses charged particles, such as protons, neutrons, or heavier ions (such as carbon), to treat cancer. Its greatest advantage is the Bragg peak, which occurs when particles deposit the majority of their energy at a given depth, allowing for accurate tumor targeting while limiting harm to adjacent healthy tissues. This precision makes particle therapy especially useful for cancers that are resistant to traditional photon-based therapies.
- Furthermore, particle therapy is used to treat a variety of diseases, including brain tumors, prostate cancer, and pediatric malignancies, with fewer side effects and a higher quality of life for patients than standard radiation techniques.
>>> Get | Download Sample Report @ –https://www.verifiedmarketresearch.com/download-sample/?rid=40167
Global Particle Therapy Market Dynamics
The key market dynamics that are shaping the Particle Therapy Market include:
Key Market Drivers
- Rising Cancer Incidence: The growing prevalence of cancer worldwide is a primary driver of the Particle Therapy Market. According to the World Health Organization (WHO), cancer is the biggest cause of death worldwide, accounting for approximately 10 million deaths in 2020. According to the International Agency for Research on Cancer (IARC), there were 19.3 million new cancer cases worldwide in 2020, with the number expected to climb to 28.4 million by 2040. The expanding cancer burden is generating demand for innovative treatment methods such as particle therapy, which provides focused treatment with possibly fewer side effects than conventional radiotherapy.
- Technological Advancements in Particle Therapy: Continuous technological advancements in particle treatment systems are broadening their applications and fueling market expansion. According to the National Cancer Institute (NCI), 37 particle therapy centers were in operation in the United States in 2021, with several more under construction or in the planned stages. According to the Particle Therapy Co-Operative Group (PTCOG) statistics, there were 103 particle therapy facilities in operation globally as of 2021, with an additional 41 under construction. This rapid growth of facilities reflects the increasing adoption and technological maturity of particle therapy systems.
- Increasing Healthcare Expenditure: Rising healthcare spending, particularly in industrialized countries, is accelerating the adoption of innovative cancer treatment methods such as particle therapy. According to the Organization for Economic Cooperation and Development (OECD), health spending in OECD countries increased faster than economic growth in 2019, accounting for 8.8% of GDP on average. According to the Centers for Medicare and Medicaid Services (CMS), national health spending increased by 9.7% to USD 4.1 Trillion in 2020, or $12,530 per person. This increased healthcare spending allows for investments in cutting-edge treatments such as particle therapy, which drives market growth.
Key Challenges:
- High Operational Costs: Establishing and operating particle therapy centers necessitates significant investment in advanced technology, such as cyclotrons and synchrotrons, which are prohibitively expensive for many healthcare facilities. This financial barrier reduces the number of available treatment centers, particularly in developing countries, limiting patient access to this new medicine and impeding overall market growth.
- Limited Awareness among Healthcare Providers: Despite the benefits of particle therapy, many oncologists and healthcare professionals remain unaware of its advantages over traditional treatments. This awareness gap results in the underutilization of particle therapy alternatives, as patients are not recommended for advanced therapies. Increased education and training for healthcare practitioners are critical to increasing adoption rates and improving patient outcomes in cancer treatment.
Key Trends:
- Growing Prevalence of Cancer: The need for advanced treatment modalities like particle therapy is growing as the number of new cases of cancer is expected to reach 20 million worldwide in 2022. This trend is encouraging healthcare practitioners to use novel therapies that reduce damage to healthy tissues while efficiently treating malignancies, thereby improving patient outcomes and quality of life.
- Increased Investment in Healthcare Infrastructure: Countries in Asia Pacific, including Japan and China, are making significant investments to develop more particle therapy centers. This infrastructure expansion is critical for supporting the growing demand for advanced cancer treatments, which is driven by a large target population and significant unmet clinical needs. Improved access to particle therapy is expected to accelerate its adoption in these regions.
What's inside a VMR
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=40167
Global Particle Therapy Market Regional Analysis
Here is a more detailed regional analysis of the Particle Therapy Market:
North America:
- According to Verified Market Research, North America is estimated to dominate the market during the forecast period. North America, particularly the United States, has a high cancer burden, which drives the desire for sophisticated treatment options such as particle therapy. According to the American Cancer Society’s Cancer Facts & Figures 2023, the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. The National Cancer Institute estimates that 39.5% of men and women will be diagnosed with cancer at some point in their lives. This high incidence rate is a major driving force behind the region’s adoption of novel cancer treatments such as particle therapy.
- Furthermore, North America has a robust healthcare research and development ecosystem, which fosters advances in cancer treatment technology. The National Cancer Institute (NCI) states that it got $6.9 billion for cancer research in fiscal year 2022, with a significant portion of that going toward discovering and refining cancer treatment modalities. Also, the Particle Therapy Co-Operative Group (PTCOG) said that as of 2021, 37 particle treatment facilities were in operation in North America, with several more under construction or in the planning phases. This concentration of research funds and infrastructure demonstrates the region’s commitment to developing particle therapy methods and treatments.
Asia Pacific:
- The Asia Pacific region is estimated to exhibit the highest growth within the market during the forecast period. The Asia-Pacific region has experienced a huge increase in cancer diagnoses, fueling demand for innovative treatment alternatives such as particle therapy. According to the World Health Organization’s International Agency for Research on Cancer (IARC), the Asia-Pacific region accounted for 49.3% of all new cancer cases worldwide in 2020. According to GLOBOCAN 2020 data, there were approximately 9.5 million new cancer cases in Asia in 2020, with the number expected to rise to 14.7 million by 2040. This significant and growing cancer burden is a crucial factor in the region’s adoption of novel cancer treatments like particle therapy.
- Furthermore, many Asian countries are aggressively promoting the research and application of innovative medical technologies, such as particle therapy. For example, Japan, a leader in particle therapy in Asia, has received major government backing for this technique. According to the Particle Therapy Co-Operative Group (PTCOG), Japan has the most particle therapy facilities in Asia, with 20 operational as of 2021. The Japanese government has designated particle treatment as an “advanced medical technology” and is providing financial assistance for its development and deployment. Similarly, countries such as China and South Korea are rapidly growing their particle therapy capabilities, with official support.
Global Particle Therapy Market: Segmentation Analysis
The Particle Therapy Market is segmented on the basis of Type, Product, and Cancer Type.
Particle Therapy Market, By Type
- Proton Therapy
- Heavy Ion Therapy
Based on Type, the market is segmented into Proton Therapy and Heavy Ion Therapy. The proton therapy segment is estimated to dominate the Particle Therapy Market due to proton therapy’s precision targeting capabilities, which enable the effective treatment of many malignancies while minimizing damage to adjacent healthy tissues. Its improved dose distribution and low long-term adverse effects make it especially appealing for pediatric cases and complicated cancers, resulting in widespread acceptance among healthcare providers and patients. As technology advances and treatment delivery improves, proton therapy’s position as the top choice in particle therapy is projected to strengthen further.
Particle Therapy Market, By Product
- Cyclotrons
- Synchrotrons
- Synchrocyclotrons
Based on Product, the Particle Therapy Market is segmented into Cyclotrons, Synchrotrons, and Synchrocyclotrons. The cyclotrons segment is estimated to dominate the market over the forecast period. Cyclotrons are critical components of proton therapy systems, producing and accelerating protons to provide targeted radiation to malignancies. Their broad use is driven by their efficacy in treating a variety of malignancies, including pediatric instances and complicated tumors. As healthcare facilities spend more on innovative cancer treatment technologies, the need for cyclotrons is likely to increase, strengthening their market dominance.
Particle Therapy Market, By Cancer Type
- Pediatric Cancer
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Others
Based on Cancer Type, the market is divided into Pediatric Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, and Others. The pediatric cancer segment is estimated to dominate the global market due to a growing knowledge of children’s unique therapeutic demands, which are particularly vulnerable to radiation. Particle therapy’s precision reduces damage to surrounding healthy tissues, making it an excellent choice for treating pediatric cancers. As knowledge of the efficacy and safety of particle therapy in younger patients grows, this segment is projected to maintain its market leadership.
Key Players
The “Particle Therapy Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Accuray Incorporated, Brainlab, Elekta AB, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, IBA Worldwide, Panacea, and Shinva Medical Instrument Co. Ltd.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Particle Therapy Market Recent Developments
- In September 2023, Siemens Healthineers AG showcased breakthrough technology at the American Society for Radiation Oncology (ASTRO) 2023 annual meeting in California, demonstrating their dedication to innovation and improved results.
Report Scope
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| STUDY PERIOD | 2020-2031 |
| BASE YEAR | 2023 |
| FORECAST PERIOD | 2024-2031 |
| HISTORICAL PERIOD | 2020-2022 |
| UNIT | Value (USD Million) |
| KEY COMPANIES PROFILED | Accuray Incorporated, Brainlab, Elekta AB, xstrahl, Danfysik A/S, Hitachi Ltd., Mevion Medical Systems, IBA Worldwide, Panacea, and Shinva Medical Instrument Co. Ltd. |
| SEGMENTS COVERED | By Type, By Product, By Cancer Type, And By Geography |
| CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Research Methodology of Verified Market Research:
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our sales team at Verified Market Research.
Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Frequently Asked Questions
1 INTRODUCTION OF GLOBAL PARTICLE THERAPY MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL PARTICLE THERAPY MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 GLOBAL PARTICLE THERAPY MARKET, BY TYPE
5.1 Overview
5.2 Heavy Ion
5.3 Proton Therapy
6 GLOBAL PARTICLE THERAPY MARKET, BY PRODUCT
6.1 Overview
6.2 Cyclotrons
6.3 Synchrotrons
6.4 Synchrocyclotrons
7 GLOBAL PARTICLE THERAPY MARKET, BY APPLICATION
7.1 Overview
7.2 Treatment Application
7.3 Research Application
8 GLOBAL PARTICLE THERAPY MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
8.5.1 Latin America
8.5.2 Middle East and Africa
9 GLOBAL PARTICLE THERAPY MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 COMPANY PROFILES
10.1 Accuray Incorporated
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Brainlab
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Elekta AB
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Xstrahl
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Danfysik A/S
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Hitachi Ltd
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Mevion Medical Systems
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 IBA Worldwide
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Panacea
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
10.10 Shinva Medical Instrument Co. Ltd.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments
11 Appendix
11.1 Related Research
Report Research Methodology
Verified Market Research uses the latest researching tools to offer accurate data insights. Our experts deliver the best research reports that have revenue generating recommendations. Analysts carry out extensive research using both top-down and bottom up methods. This helps in exploring the market from different dimensions.
This additionally supports the market researchers in segmenting different segments of the market for analysing them individually.
We appoint data triangulation strategies to explore different areas of the market. This way, we ensure that all our clients get reliable insights associated with the market. Different elements of research methodology appointed by our experts include:
Exploratory data mining
Market is filled with data. All the data is collected in raw format that undergoes a strict filtering system to ensure that only the required data is left behind. The leftover data is properly validated and its authenticity (of source) is checked before using it further. We also collect and mix the data from our previous market research reports.
All the previous reports are stored in our large in-house data repository. Also, the experts gather reliable information from the paid databases.
For understanding the entire market landscape, we need to get details about the past and ongoing trends also. To achieve this, we collect data from different members of the market (distributors and suppliers) along with government websites.
Last piece of the ‘market research’ puzzle is done by going through the data collected from questionnaires, journals and surveys. VMR analysts also give emphasis to different industry dynamics such as market drivers, restraints and monetary trends. As a result, the final set of collected data is a combination of different forms of raw statistics. All of this data is carved into usable information by putting it through authentication procedures and by using best in-class cross-validation techniques.
Data Collection Matrix
| Perspective | Primary Research | Secondary Research |
|---|---|---|
| Supplier side |
|
|
| Demand side |
|
|
Econometrics and data visualization model
Our analysts offer market evaluations and forecasts using the industry-first simulation models. They utilize the BI-enabled dashboard to deliver real-time market statistics. With the help of embedded analytics, the clients can get details associated with brand analysis. They can also use the online reporting software to understand the different key performance indicators.
All the research models are customized to the prerequisites shared by the global clients.
The collected data includes market dynamics, technology landscape, application development and pricing trends. All of this is fed to the research model which then churns out the relevant data for market study.
Our market research experts offer both short-term (econometric models) and long-term analysis (technology market model) of the market in the same report. This way, the clients can achieve all their goals along with jumping on the emerging opportunities. Technological advancements, new product launches and money flow of the market is compared in different cases to showcase their impacts over the forecasted period.
Analysts use correlation, regression and time series analysis to deliver reliable business insights. Our experienced team of professionals diffuse the technology landscape, regulatory frameworks, economic outlook and business principles to share the details of external factors on the market under investigation.
Different demographics are analyzed individually to give appropriate details about the market. After this, all the region-wise data is joined together to serve the clients with glo-cal perspective. We ensure that all the data is accurate and all the actionable recommendations can be achieved in record time. We work with our clients in every step of the work, from exploring the market to implementing business plans. We largely focus on the following parameters for forecasting about the market under lens:
- Market drivers and restraints, along with their current and expected impact
- Raw material scenario and supply v/s price trends
- Regulatory scenario and expected developments
- Current capacity and expected capacity additions up to 2027
We assign different weights to the above parameters. This way, we are empowered to quantify their impact on the market’s momentum. Further, it helps us in delivering the evidence related to market growth rates.
Primary validation
The last step of the report making revolves around forecasting of the market. Exhaustive interviews of the industry experts and decision makers of the esteemed organizations are taken to validate the findings of our experts.
The assumptions that are made to obtain the statistics and data elements are cross-checked by interviewing managers over F2F discussions as well as over phone calls.
Different members of the market’s value chain such as suppliers, distributors, vendors and end consumers are also approached to deliver an unbiased market picture. All the interviews are conducted across the globe. There is no language barrier due to our experienced and multi-lingual team of professionals. Interviews have the capability to offer critical insights about the market. Current business scenarios and future market expectations escalate the quality of our five-star rated market research reports. Our highly trained team use the primary research with Key Industry Participants (KIPs) for validating the market forecasts:
- Established market players
- Raw data suppliers
- Network participants such as distributors
- End consumers
The aims of doing primary research are:
- Verifying the collected data in terms of accuracy and reliability.
- To understand the ongoing market trends and to foresee the future market growth patterns.
Industry Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|---|---|
|
|
